Aprea Therapeutics, Inc. ($APRE)
Filing Information
| Accession Number | 0001104659-26-009206 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 2, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
56,200
Total Value
$25,009.00
P&L
-14.4% ($3,591.18)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 30, 2026 | Purchase | 28,100 | $0.89 | $25,009.00 | 373,720 | Direct | โ | View Details | |
Director | Common Warrant | Derivative | Jan 30, 2026 | Purchase | 28,100 | โ | โ | 28,100 | Direct | โ | View Details |